SANDOZ KOREA 49TH FI THREE IFC

Company Introduction:

Sandoz Korea is the South Korean affiliate of Sandoz, a global leader in generic and biosimilar medicines. Sandoz, a division of Novartis, plays a crucial role in increasing access to high-quality, affordable healthcare worldwide. Sandoz Korea is responsible for the commercial operations, marketing, sales, and distribution of Sandoz's portfolio of generic pharmaceuticals and biosimilars across various therapeutic areas within the Korean market. Their mission is to provide patients in Korea with access to essential medicines and sustainable healthcare solutions.

Nature of Business:

Trading Company / Commercial Office

SANDOZ KOREA 49TH FI THREE IFC manufactures or sells the following products:

* Pharmaceutical products (prescription and over-the-counter)

* Generics

* Biosimilars

* Anti-infectives

* Cardiovascular medicines

* Central nervous system medicines

* Pain management medications

* Oncology medications

* Respiratory medicines

* Gastrointestinal medicines

* Endocrine medicines